Visual function in Hungtington's disease patients and presymptomatic gene carriers

Movement Disorders

Volumn 18, Issue 9, 2003, Pages 1027-1034

  O'Donnell, Brian F ^a   Wilt, Marcia A ^a   Hake, Ann Marie ^a   Stout, Julie C ^a   Kirkwood, Sandra C ^b   Foroud, Tatiana ^b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Extraocular movements; Huntington's disease; Visual perception

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EYE MALFORMATION; EYE MOVEMENT; FEMALE; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; MALE; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; RISK ASSESSMENT; VISION TEST; VISUAL DISORDER; VISUAL MEMORY; VISUAL SYSTEM EXAMINATION; VISUOMOTOR COORDINATION; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; TASK PERFORMANCE; VISION;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; PSYCHOMOTOR PERFORMANCE; TASK PERFORMANCE AND ANALYSIS; VISUAL PERCEPTION;

EID: 0141502265     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10491     Document Type: Article

References (46)

1. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-983.
2. Bamford KA, Caine ED, Kido DK, Cox C, Shoulson I. A prospective evaluation of cognitive decline in early Huntington's disease: functional and radiographic correlates. Neurology 1995;45:1867-1873.
3. Sax DS, O'Donnell BF, Butters N, Menzer L, Montgomery K, Kayne HL. Computer tomographic, neurologic and neuropsychological correlates of Huntington's disease. Int J Neurosci 1983;18: 21-36.
4. Mohr E, Brouwers P, Claus JJ, Mann UM, Fedio P, Chase TN. Visuospatial cognition in Huntington's disease. Mov Disord 1991; 6:127-132.
5. Gomez-Tortosa E, del Barrio A, Barroso T, Garcia Ruiz PJ. Visual processing disorders in patients with Huntington's disease and asymptomatic carriers. J Neurol 1996;243:286-292.
6. Jacobs DH, Shuren J, Heilman KM. Impaired perception of facial identity and facial affect in Huntington's disease. Neurology 1995; 45:1217-1218.
7. Lawrence AD, Watkins LHA, Sahakian BJ, Hodges JR, Robbins TW. Visual object and visuospatial cognition in Huntington's Disease: implications for information processing in corticostriatal circuits. Brain 2000;123:1349-1364.
8. Backman L, Robins-Wahlin T-B, Lundin A, Ginovart N, Farde L. Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Brain 1997;120:2207-2217.
9. Joel D. Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease. Mov Disord 2001;16:407-423.
10. Blackmore L, Simpson SA, Crawford JR. Cognitive performance in UK sample of presymptomatic people carrying the gene for Huntington's disease. J Med Genet 1995;32:358-362.
11. de Boo GM, Tibben A, Lanser JBK, et al. Early cognitive and motor symptoms in identified carriers of the gene for Huntington disease. Arch Neurol 1997;54:1353-1357.
12. Strauss ME, Brandt J. Are there neuropsychologic manifestations of the gene for Huntington's disease in asymptomatic, at-risk individuals? Arch Neurol 1990;47:905-908.
13. Kirkwood S, Siemers E, Stout JC, et al. Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers. Arch Neurol 1999;56:563-568.
14. Lawrence AD, Hodges JR, Rosser AE, et al. Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 1998; 121:1329-1341.
15. Jason GW, Pajurkova EM, Suchowersky O, et al. Presymptomatic neuropsychological impairment in Huntington's disease. Arch Neurol 1988;45:769-773.
16. Campodonico JR, Codori AM, Brandt J. Neuropsychological stability over two years in asymptomatic carriers of Huntington's disease mutation. J Neurol Neurosurg Psychiatry 1996;61:621-624.
17. Rosenberg NK, Sorensen SA, Christensen A-L. Neuropsychological characteristics of Huntington's disease carriers: a double blind study. J Med Genet 1995;32:600-604.
18. Giordani B, Berent S, Boivin MJ, et al. Longitudinal neuropsychological and genetic linkage analysis of persons at risk for Huntington's disease. Arch Neurol 1995;52:59-64.
19. Hahn-Barma V, Deweer B, Durr A, et al. Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers. J Neurol Neurosurg Psychiatry 1998;64:172-177.
20. Cronin-Golomb A. Vision in Alzheimer's disease. Gerontologist 1995;35:370-376.
21. Lang CJG, Reischies FM, Majer M, Daum RF. Visually guided exploration in Huntington's disease. Cortex 1999;35:583-590.
22. Schlag J, Schlag-Rey M. Through the eye, slowly: delays and localization errors in the visual system. Nat Rev Neurosci 2002; 3:191-2000.
23. Bodis-Wollner I, Tagliati M. The visual system in Parkinson's disease. Adv Neurol 1993;60:390-394.
24. Gilmore GC, Wenk HE, Naylor LA, Koss E. Motion perception and Alzheimer's disease. J Gerontol 1994;49:52-57.
25. Goldberg YP, Andrew SE, Clarke LA, et al. A PCR method for accurate assessment of trinucleotide repeat expansion in Huntington disease. Hum Mol Genet 1993;2:635-636.
26. Bond C, Hodes ME. Direct amplification of the CAG Repeat of Huntington without amplification of CCG. Clin Chem 1996;42: 773-774.
27. Penney JB, Young BM, Shoulson I, et al. Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Mov Disord 1990;5:93-99.
28. Folstein SE, Jensen B. Leigh RJ, et al. The measurement of abnormal movement: methods developed for Huntington's disease. Neurobehav Toxicol Teratol 1983;5:605-609.
29. Siemers E, Foroud T, Bill D, et al. Motor changes in presymptomatic Huntington disease gene carriers. Arch Neurol 1996;53:487-492.
30. Wechsler D. Wechsler Adult intelligence scale-revised. New York: Psychological Corp; 1981.
31. Tyler CW, McBride B. The Morphonome image psychophysics software and calibrator for Macintosh systems. Spat Vis 1995;10: 479-484.
32. Wandell BA. Foundations of vision. Sunderland, MA: Sinauer Associates 1995.
33. Tyler CW. Analysis of normal flicker sensitivity and its variability in the visuogram test. Inv Opthalmol Vis Sci 1991;32:2552-2560.
34. Farmer CM, O'Donnell BF, Niznikiewicz MA, Voglmaier MM, McCarley RW, Shenton ME. Visual perception and working memory in schizotypal personality disorder. Am J Psychol 2000;157: 781-786.
35. Levitt H. Transformed up-down methods in psychoacoustics. J Acoust Soc Am 1971;49:467-470.
36. Zeki S. A vision of the brain. Oxford, UK: Blackwell Scientific Publications; 1993.
37. Rees G, Friston K, Koch C. A direct quantitative relationship between the functional properties of human and macaque V5. Nat Neurosci 2000;3:716-723.
38. Bookstein FL, Sampson PD, Streissguth AP, Barr HM. Exploiting redundant measurement of dose and developmental outcome: new methods from the behavioral teratology of alcohol. Dev Psychol 1996;32:404-415.
39. O'Donnell BF, McCarley RW, Potts GF, et al. Identification of neural circuits underlying P300 abnormalities in schizophrenia. Psychophysiology 1999;36:388-398.
40. Karrer R, Cohen J, Tueting P. Brain and Information: event-related potentials. Ann N Y Acad Sci 1984;425:591-597.
41. Oepen G, Doerr M, Thoden U. Visual (VEP) and somatosensory (SSEP) evoked potentials is Huntington's chorea. Electroencephalogr Clin Neurophysiol 1981;51:666-670.
42. Ellenberger JC, Petro DJ, Ziegler SB. The visual evoked potentials in Huntington disease. Neurology 1978;28:95-97.
43. Ehle AL, Stewart RM, Lellelid NA, Leventhal NA. Evoked potentials in Huntington's disease: a comparative and longitudinal study. Arch Neurol 1984;41:379-382.
44. Rosas HD, Liu AK, Hersch S, et al. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 2002;58:695-701.
45. Bodis-Wollner I, Bucher SF, Seelos KC, Paulus W, Reiser M, Oertel WH. Functional MRI mapping of occipital and frontal cortical activity during voluntary and imagined saccades. Neurology 1997;49:416-420.
46. Pierrot-Deseilligny C. Saccade and smooth-pursuit impairment after cerebral hemispheric lesions. Eur Neurol 1994;34:121-134.